上调的DDX39在上皮上腺癌中与患者的生存率有关

Yoshiatsu Tanaka1, Shin-Nosuke Yamashita1, Shajedul Islam1

  • 1Advanced Research Promotion Centre, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.

Anticancer research
|January 31, 2025
PubMed
概括

高DDX39表达表明上腺皮癌的预后不佳. 这种RNA螺旋酶可能作为这种罕见而具有攻击性的上皮层癌症的新奇预后生物标志物.